Received: from AS4P195CA0045.EURP195.PROD.OUTLOOK.COM (2603:10a6:20b:65a::18)
 by GV4PR02MB11255.eurprd02.prod.outlook.com (2603:10a6:150:299::12) with
 Microsoft SMTP Server (version=TLS1_2,
 cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.615.14; Thu, 19 Nov
 2026 09:00:32 +0000
Received: from GV4PR02MB11255.eurprd02.prod.outlook.com
 (2603:10a6:150:299::12) by BR0PR02MB142346.eurprd02.prod.outlook.com with
 HTTPS; Thu, 19 Nov 2026 09:00:35 +0000
Received: from mail1.rit.ee (213.184.53.4) by
 AM2PEPF00070CF3.mail.protection.outlook.com (10.167.242.5) with Microsoft
 SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.639.5
 via Frontend Transport; Thu, 19 Nov 2026 09:00:31 +0000
Received: from AM2PEPF00070CF3.eurprd02.prod.outlook.com
 (2603:10a6:20b:65a:cafe::16) by AS4P195CA0045.outlook.office365.com
 (2603:10a6:20b:65a::18) with Microsoft SMTP Server (version=TLS1_3,
 cipher=TLS_AES_256_GCM_SHA384) id 15.21.639.10 via Frontend Transport; Thu,
 19 Nov 2026 09:00:32 +0000
Reply-To: =?utf-8?Q?Marju_Pe=C3=A4rnberg?= <marju.pearnberg@ee.abb.com>
From: "Sotsiaalministeerium" <info@sm.ee>
To: "Info - SOM" <info@sm.ee>
Subject: Kas on kantserogeenne protsess
Date: Thu, 19 Nov 2026 11:00:30 +0200
Keywords: Mall
Message-ID: <80ca6e3293ca31d8e66a35f0edb94ab5@sm.ee>
MIME-Version: 1.0
Content-Type: multipart/alternative;
	boundary="----=_NextPart_000_00EF_01DD783E.F5BECA90"
X-Mailer: Microsoft Outlook 16.0
Thread-Index: AQJ2xXaWZy2FF1auprpmuKHla+I7gw==
Authentication-Results: mx.microsoft.com 1; spf=pass (sender IP is
 213.184.53.4) smtp.mailfrom=sm.ee; dkim=pass (signature was verified)
 header.d=sm.ee;dkim=pass (signature was verified) header.d=sm.ee;dmarc=pass
 action=none header.from=sm.ee;compauth=pass reason=100
X-CSE-ConnectionGUID: U/3EiHtxQFeN+Nueg65xrQ==
X-CSE-ConnectionGUID: zUnMzYQwS2e5MpNJaFRY0w==
X-CSE-MsgGUID: g7vCpbGNSkKm/fDTMsGAjQ==
X-CSE-MsgGUID: a1YYkxTgRZmKDBHRk1axQA==
X-ThreatScanner-Verdict: Negative
X-Talos-CUID: 9a23:DL2qOmBfhJpkP7/6Ezta8msGK/k6SSfQkVLIBW2xJ1xYEKLAHA==
X-Talos-MUID: =?us-ascii?q?9a23=3AsnrIsQ+35TiinaS0+B9VAg6Qf84x0pWtGHwCq6c?=
 =?us-ascii?q?DmOWuFRZzYj6NtR3iFw=3D=3D?=
X-IronPort-Anti-Spam-Filtered: False
X-IronPort-AV: E=Sophos;i="6.27,220,1787000400"; 
   d="scan'208,217";a="86460740"
X-Amp-Result: SKIPPED(no attachment in message)
X-Amp-File-Uploaded: False
X-MS-Exchange-Organization-ExpirationStartTime: 19 Nov 2026 09:00:31.7459
 (UTC)
X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit
X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000
X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit
X-MS-Exchange-Organization-Network-Message-Id: 60089c1e-85e1-423f-331e-08df461b90cf
X-EOPAttributedMessage: 0
X-EOPTenantAttributedMessage: 8fe098d2-428d-4bd4-9803-7195fe96f0e2:0
X-MS-Exchange-Organization-MessageDirectionality: Incoming
X-MS-PublicTrafficType: Email
X-MS-TrafficTypeDiagnostic: AM2PEPF00070CF3:EE_|GV4PR02MB11255:EE_|BR0PR02MB142346:EE_
X-MS-Exchange-Organization-AuthSource: AM2PEPF00070CF3.eurprd02.prod.outlook.com
X-MS-Exchange-Organization-AuthAs: Anonymous
X-MS-Office365-Filtering-Correlation-Id: 60089c1e-85e1-423f-331e-08df461b90cf
X-MS-Exchange-AtpMessageProperties: SA|SL
X-DisclaimerOO: 1
X-MS-Exchange-Organization-SCL: -1
X-Microsoft-Antispam: BCL:0;ARA:13230040|260918224100599003|260918215300599003|82310400026|10067099003|261026140227099003|5063699009|11063799006|261022105027099003|261028144727099003|57112099003|55112099003|19002099009|261009223027099003|8096899003|18003699003;
X-Forefront-Antispam-Report: CIP:213.184.53.4;CTRY:EE;LANG:et;SCL:-1;SRV:;IPV:CAL;SFV:NSPM;H:mail1.rit.ee;PTR:mail1.rit.ee;CAT:NONE;SFS:(13230040)(260918224100599003)(260918215300599003)(82310400026)(10067099003)(261026140227099003)(5063699009)(11063799006)(261022105027099003)(261028144727099003)(57112099003)(55112099003)(19002099009)(261009223027099003)(8096899003)(18003699003);DIR:INB;
X-MS-Exchange-CrossTenant-OriginalArrivalTime: 19 Nov 2026 09:00:31.6230
 (UTC)
X-MS-Exchange-CrossTenant-Network-Message-Id: 60089c1e-85e1-423f-331e-08df461b90cf
X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2
X-MS-Exchange-CrossTenant-AuthSource: AM2PEPF00070CF3.eurprd02.prod.outlook.com
X-MS-Exchange-CrossTenant-AuthAs: Anonymous
X-MS-Exchange-CrossTenant-FromEntityHeader: Internet
X-MS-Exchange-Transport-CrossTenantHeadersStamped: GV4PR02MB11255
X-MS-Exchange-Transport-EndToEndLatency: 00:00:04.2365748
X-MS-Exchange-Processed-By-BccFoldering: 15.21.0639.000
X-MS-Exchange-ExternalInOutlookResult: NotEnabled
X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(920097)(930201)(20251009284)(140003);
X-Microsoft-Antispam-Message-Info: =?us-ascii?Q?zqop9oHWIjR2IvGEmXZKRzVwdoj8yghPFEY7FlMt7rgPfXqk4+CBMnMRrYJl?=
 =?us-ascii?Q?0FwbHOKNTnwDnsGzMThHGlZ1WAhP6se4VY4265ANWNyEWTt2aGrlesCHBjBD?=
 =?us-ascii?Q?SpYSGunnSY94HnhX7+SkDa2MUTbD4Ueu1U0BCMiHtnXDAPLk+eaJiDbQzYWT?=
 =?us-ascii?Q?zlLPqZEJcJKKhWQspfQ1UN72ymN4riCQ4FfXkGIqp75PKKpYBNym46V6tAld?=
 =?us-ascii?Q?cj1nyQnkm4yyBL1c1kyw9YTMtFjHKz+u4rqR+SPOqQuqUonwNm5SvV5VvS43?=
 =?us-ascii?Q?UpWURjO6WTIZs3IPOphnw0tFpz9jARTDaV7P0c80jV492fvL/E6aAXNrBsDJ?=
 =?us-ascii?Q?RyjvoTkJylw3SlgEnthdHmvON22YmGOsv7+koaqN9M+wseBgexEyfjwl/KMb?=
 =?us-ascii?Q?RppvLHxwKAGHf63LXY+15Qm1rPQf1jsOs0HHCfz6fnWjJxLhHxkD7NgARgKg?=
 =?us-ascii?Q?xkVtViDcT0+U7IIa5E1eG/M2m5LzevkZgA3VmvJC/r7Preo0Hhb+e31FAT1C?=
 =?us-ascii?Q?eiulS2HelXBdLwM3rU9ocTAhmnSi6wgjzxKpJCkSAmQOs9CUHqMJToWOpbUp?=
 =?us-ascii?Q?xse5CRAnL5yTqxYUGStlT4e3ny6IKaKT0vadORmswQecjnDNM80s+qKD4i3O?=
 =?us-ascii?Q?AhSUBywl5nAsl+qujskaXsMt/Qh7BTyoktvDT3JeQnJsgFPCreftUWdO3YmU?=
 =?us-ascii?Q?+EXuilBzwmifrkhxInQLArDQ7PYjFFdjB1vF92Ple6diKQXWOyh
	ZSVWqqLiW?=
 =?us-ascii?Q?/qunVlX3KYpM6ZB4A5LJcGkQXztpPSHluNrJRqsQpErne/Sm3IWlo03nYV6I?=
 =?us-ascii?Q?JzCVYRvFVGLN7S7uNpa5jA6SeXeGulu7dH2QDPOGk4f1zMPw+C3fae4oCPVO?=
 =?us-ascii?Q?/DKg0A8dNEYquGuy+77ygEYZRuiLq2uWggJlhm9bLvnKEf0ZAFVhPq6X5pj+?=
 =?us-ascii?Q?apoimGE4D9yZrTMRV+j/lusfwaxohjKO5BZS7bToUwCN98wgT7h91QNqG120?=
 =?us-ascii?Q?OYEhj14SCC0+iNWXzzV3bk3xNbmw6ai4GZIHAbTqC9HQiCwHsiMawwVrtM/C?=
 =?us-ascii?Q?2TFFb/sbBIEZY5MhqdxWETGs9kHNR1NYHq+2oPCKNb8MNwHeRJMt0aQAsz+V?=
 =?us-ascii?Q?S0eY9gYKEyCYNAQaopW26/rI3bMGZQyp+RebfQj0E+piGkghICc4Qm2U0PP8?=
 =?us-ascii?Q?pB2kj6vbLuwtDvv86iJ3KS6vzt0JafiCohT0pdnYBpvNNnvUydt+/xGIOc9a?=
 =?us-ascii?Q?gQtehmET5h2rjj6Pwv2nyDD1ZmPhQAvKjWQyxCZL4u/NSvoxnhn6jwlMk4TQ?=
 =?us-ascii?Q?MfT4cMtHOas5T0K5Hx8GVGAxQSQN3pHnAEgW9/FgtMTnmljDe3AFaxMbqY/W?=
 =?us-ascii?Q?xFCpXti5lqjjDAp9DaKE/xOMgoZzX/VKpjDsJvm8TX/mDlTx/AL8fa0UOTCq?=
 =?us-ascii?Q?uAKwffQ2Ymo3jWw1o2SziQV0gatSSTF/z7jrH3NUVv/uPjpueWDDcAltoX+r?=
 =?us-ascii?Q?gsY4OIhXwHMK9i6APbHk0gQHibMgo306XBu9e
	l2TlqD5c2ZMQmumZYxofoeI?=
 =?us-ascii?Q?sZMsY0HovBVC5JSdJmF9S1ULJ9HgoVuSnMo+4941dhZva2ipWAGkpjbpp6mq?=
 =?us-ascii?Q?mWoZF+Nd+2xkOEshPI+fpsAnm1fEUrKReoTpIrUSpdZCCvPqdQsPzzN7OuRr?=
 =?us-ascii?Q?GYPP4Qd4/n0kzlFDlJI61Z29VNUZuUozYVCq9wl8Y9WaoK16sD/kWwpEQmO2?=
 =?us-ascii?Q?GXt1wz2PNlRKmmc/XL51JBKpB9DqMkD9zvcnM+wEHL0tv2hBOE1S?=
Content-Language: en-us
x-ms-exchange-organization-originalclientipaddress: 213.184.53.4
x-ms-exchange-organization-originalserveripaddress: 10.167.242.5
received-spf: None (mail1.rit.ee: no sender authenticity  information available from domain of  postmaster@mailgw12.rmit.ee) identity=helo;  client-ip=195.80.115.29; receiver=mail1.rit.ee;  envelope-from="info@sm.ee";  x-sender="postmaster@mailgw12.rmit.ee";  x-conformance=spf_only
dkim-signature: v=1; a=rsa-sha256; c=relaxed/simple;  d=sm.ee; s=mailrmit;  h=sender:subject:from:reply-to:to:message-id:date;  bh=84lyrbEIRLjeKvcjXAsn60dYCLLV3X0IDDtgPkvTqHM=;  b=ok/eBry8KRp+hQTsaXuMZhXOTqBEGt1dEDMIal47w9uaQ16prVpnNSX4   05xe3lBWVOFusBU6ps6EZwcorY2Mx6jtjH7z0hGFWUL7kBl9ig78Oo4Ge   TqRWGaGkvHxs0EKgFvL6D4sCSqYOsLyYPk2MQv10kpyRrFHrutxg5N+pM   X5/2eKzz7wdLtZuijLtSoPjpuJPgjAckBu4KTyqzSOSrnx5eLL1jwz/SX   7uiG9N7GtlfWltb5MOEbHGV2Dz9V0HOpsT5ducOBMSWUkwkvaqlRKrKXf   U8dVhVwHRYj44TS1dVvrd4wMya4KIvhmO/p5kivpnvE3gri6W8NIwfxy4   Q==;
X-OlkEid: 00000000D07AAE8E23CDBE4CA04D01CCD82FCB7E070034AD76187591974DBF6C4F76951C873A01000200000000005797C783AAECB34FA6C879FF487E64D900000000119C00001878D9F84CC1B14D8674EA81A8BF7BB4

This is a multipart message in MIME format.

------=_NextPart_000_00EF_01DD783E.F5BECA90
Content-Type: text/plain;
	charset="utf-8"
Content-Transfer-Encoding: 8bit


Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga.
Tundmatu saatja korral palume linke ja faile mitte avada.



Sisestuse kuupäev N, 19/11/2026 - 10:53

Sisestaja: vportal_rest

Sisestatud veebivormi info:

Esitaja nimi
Marju Peärnberg

Esitaja e-post
marju.pearnberg@ee.abb.com <mailto:marju.pearnberg@ee.abb.com>

Pealkiri
Kas on kantserogeenne protsess

Küsimuse või ettepaneku sisu
Tere. Soovin teada, kas jootmisel tekkivad Cu aerosoolid on CMRD kemikaa või 
protsessl.
EUROOPA PARLAMENDI JA NÕUKOGU DIREKTIIV 2004/37/EÜ EUROOPA PARLAMENDI JA 
NÕUKOGU DIREKTIIV 2004/37/EÜ I lisa: Tööprotsessid, kus puututakse kokku 
vasknikkelmattide särdamisel ja elektrorafineerimisel tekkivate tolmude, 
suitsude ja sumudega
Eesti määruses Ohtlike kemikaalide ja neid sisaldavate materjalide 
kasutamise töötervishoiu ja tööohutuse nõuded ning töökeskkonna keemiliste 
ohutegurite piirnormid ja keemiliste ohutegurite mõõtmise kord1
§3 on: 3) vaske ja niklit sisaldavate materjalide jootmine, keevitamine või 
muu termiline töötlemine, mille käigus tekib nende metallide tolmu, suitsu 
või aerosooli;
Särdamine tähendab sulfiidse materjali kuumutamist õhu või hapniku 
juuresolekul, et eemaldada väävel.

Eesti õigusaktis ja EU direktiivis on erinavad protsessid kirjeldatud kui 
kantserogeensed.
Soovime selgust saada, kummast õigusaktist me lähtume ja kas Cu lattide 
jootmisest tuleneb aerosool jne on kantserogeenne protsess.
Tänan




------=_NextPart_000_00EF_01DD783E.F5BECA90
Content-Type: text/html;
	charset="utf-8"
Content-Transfer-Encoding: quoted-printable

<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" =
"http://www.w3.org/TR/REC-html40/loose.dtd"><html style=3D"box-sizing: =
border-box; font-family: sans-serif; line-height: 1.15; =
-webkit-text-size-adjust: 100%; -webkit-tap-highlight-color: =
rgba(0,0,0,0); --blue: #003087; --indigo: #006eb5; --purple: #6f42c1; =
--pink: #e83e8c; --red: #BA432A; --orange: #fd7e14; --yellow: #ffc107; =
--green: #3fc380; --teal: #20c997; --cyan: #17a2b8; --white: #fff; =
--gray: #75787B; --gray-dark: #343a40; --primary: #006eb5; --secondary: =
#003087; --success: #3fc380; --info: #006eb5; --warning: #BA432A; =
--danger: #BA432A; --light: #EEEEEE; --dark: #000000; --breakpoint-xs: =
0; --breakpoint-sm: 576px; --breakpoint-md: 768px; --breakpoint-lg: =
992px; --breakpoint-xl: 1261px; --font-family-sans-serif: =
'Roboto','Segoe UI','Helvetica Neue',Arial,'Noto Sans',sans-serif,'Apple =
Color Emoji','Segoe UI Emoji','Segoe UI Symbol','Noto Color Emoji'; =
--font-family-monospace: =
SFMono-Regular,Menlo,Monaco,Consolas,'Liberation Mono','Courier =
New',monospace;"><head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; =
charset=3Dutf-8">
</head>
<body style=3D"box-sizing: border-box; margin: 0; font-family: =
'Roboto','Segoe UI','Helvetica Neue',Arial,'Noto Sans',sans-serif,'Apple =
Color Emoji','Segoe UI Emoji','Segoe UI Symbol','Noto Color Emoji'; =
font-size: 1rem; font-weight: 400; line-height: 1.43; color: #000; =
text-align: left; background-color: #fff;">
<table class=3D"MsoNormalTable" border=3D"0" cellspacing=3D"0" =
cellpadding=3D"0" align=3D"left" width=3D"100%" =
style=3D"width:100.0%;mso-cellspacing:0cm;mso-yfti-tbllook:1184; =
mso-table-lspace:2.25pt;mso-table-rspace:2.25pt;mso-table-anchor-vertical=
:paragraph;mso-table-anchor-horizontal:column;mso-table-left:left;mso-pad=
ding-alt:0cm 0cm 0cm 0cm">
<tbody>
<tr =
style=3D"mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes">
<td style=3D"background:#910A19;padding:5.25pt 1.5pt 5.25pt 1.5pt"></td>
<td width=3D"100%" =
style=3D"width:100.0%;background:#FDF2F4;padding:5.25pt 3.75pt 5.25pt =
11.25pt; word-wrap:break-word" cellpadding=3D"7px 5px 7px 15px" =
color=3D"#212121">
<div>
<p class=3D"MsoNormal" =
style=3D"mso-element:frame;mso-element-frame-hspace:2.25pt; =
mso-element-wrap:around;mso-element-anchor-vertical:paragraph;mso-element=
-anchor-horizontal: column;mso-height-rule:exactly">
<span style=3D"font-size:9.0pt;font-family: &quot;Segoe =
UI&quot;,sans-serif;mso-fareast-font-family:&quot;Times New =
Roman&quot;;color:#212121"><strong>T=C3=A4helepanu!
</strong>Tegemist on v=C3=A4lisv=C3=B5rgust saabunud kirjaga.<br>
Tundmatu saatja korral palume linke ja faile mitte =
avada.<o:p></o:p></span></p>
</div>
</td>
</tr>
</tbody>
</table>
<div>
<div class=3D"email-type-webform =
email-sub-type-esita-poordumine-email-notification" style=3D"box-sizing: =
border-box;">
<table width=3D"100%" cellpadding=3D"0" cellspacing=3D"0" =
role=3D"presentation" style=3D"box-sizing: border-box; border-collapse: =
collapse;">
<tbody>
<tr style=3D"box-sizing: border-box;">
<td style=3D"box-sizing: border-box; font-family: Arial; font-size: =
16px;">
<div style=3D"box-sizing: border-box; padding: 0px 0px 0px 0px;" =
class=3D"clearfix"><style type=3D"text/css" style=3D"box-sizing: =
border-box;">
table tr td {
  font-family: Arial;
  font-size: 16px;
}
</style>
<div style=3D"box-sizing: border-box;">
<table width=3D"800px" cellpadding=3D"0" cellspacing=3D"0" =
style=3D"box-sizing: border-box; border-collapse: collapse;">
<tbody>
<tr style=3D"box-sizing: border-box;">
<td style=3D"box-sizing: border-box; font-family: Arial; font-size: =
16px;">
<div style=3D"box-sizing: border-box; padding: 0px 0px 0px 0px;">
<p style=3D"box-sizing: border-box; line-height: 1.5; margin-top: 0; =
margin-bottom: 1.15em !important;">
Sisestuse kuup=C3=A4ev N, 19/11/2026 - 10:53</p>
<p style=3D"box-sizing: border-box; line-height: 1.5; margin-top: 0; =
margin-bottom: 1.15em !important;">
Sisestaja: vportal_rest</p>
<p style=3D"box-sizing: border-box; line-height: 1.5; margin-top: 0; =
margin-bottom: 1.15em !important;">
Sisestatud veebivormi info:</p>
<b style=3D"box-sizing: border-box; font-weight: 700;">Esitaja =
nimi</b><br style=3D"box-sizing: border-box;">
Marju Pe=C3=A4rnberg<br style=3D"box-sizing: border-box;">
<br style=3D"box-sizing: border-box;">
<b style=3D"box-sizing: border-box; font-weight: 700;">Esitaja =
e-post</b><br style=3D"box-sizing: border-box;">
<a href=3D"mailto:marju.pearnberg@ee.abb.com" style=3D"box-sizing: =
border-box; color: #003087; background-color: rgba(0,0,0,0); =
font-weight: 500; text-decoration: =
underline;">marju.pearnberg@ee.abb.com</a><br style=3D"box-sizing: =
border-box;">
<br style=3D"box-sizing: border-box;">
<b style=3D"box-sizing: border-box; font-weight: 700;">Pealkiri</b><br =
style=3D"box-sizing: border-box;">
Kas on kantserogeenne protsess<br style=3D"box-sizing: border-box;">
<br style=3D"box-sizing: border-box;">
<b style=3D"box-sizing: border-box; font-weight: 700;">K=C3=BCsimuse =
v=C3=B5i ettepaneku sisu</b><br style=3D"box-sizing: border-box;">
Tere. Soovin teada, kas jootmisel tekkivad Cu aerosoolid on CMRD kemikaa =
v=C3=B5i protsessl.<br style=3D"box-sizing: border-box;">
EUROOPA PARLAMENDI JA N=C3=95UKOGU DIREKTIIV 2004/37/E=C3=9C EUROOPA =
PARLAMENDI JA N=C3=95UKOGU DIREKTIIV 2004/37/E=C3=9C I lisa: =
T=C3=B6=C3=B6protsessid, kus puututakse kokku vasknikkelmattide =
s=C3=A4rdamisel ja elektrorafineerimisel tekkivate tolmude, suitsude ja =
sumudega<br style=3D"box-sizing: border-box;">
Eesti m=C3=A4=C3=A4ruses Ohtlike kemikaalide ja neid sisaldavate =
materjalide kasutamise t=C3=B6=C3=B6tervishoiu ja t=C3=B6=C3=B6ohutuse =
n=C3=B5uded ning t=C3=B6=C3=B6keskkonna keemiliste ohutegurite =
piirnormid ja keemiliste ohutegurite m=C3=B5=C3=B5tmise kord1<br =
style=3D"box-sizing: border-box;">
=C2=A73 on: 3) vaske ja niklit sisaldavate materjalide jootmine, =
keevitamine v=C3=B5i muu termiline t=C3=B6=C3=B6tlemine, mille =
k=C3=A4igus tekib nende metallide tolmu, suitsu v=C3=B5i aerosooli;
<br style=3D"box-sizing: border-box;">
S=C3=A4rdamine t=C3=A4hendab sulfiidse materjali kuumutamist =C3=B5hu =
v=C3=B5i hapniku juuresolekul, et eemaldada v=C3=A4=C3=A4vel.<br =
style=3D"box-sizing: border-box;">
<br style=3D"box-sizing: border-box;">
Eesti =C3=B5igusaktis ja EU direktiivis on erinavad protsessid =
kirjeldatud kui kantserogeensed.<br style=3D"box-sizing: border-box;">
Soovime selgust saada, kummast =C3=B5igusaktist me l=C3=A4htume ja kas =
Cu lattide jootmisest tuleneb aerosool jne on kantserogeenne =
protsess.<br style=3D"box-sizing: border-box;">
T=C3=A4nan<br style=3D"box-sizing: border-box;">
<br style=3D"box-sizing: border-box;">
<br style=3D"box-sizing: border-box;">
</div>
</td>
</tr>
</tbody>
</table>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</div>
</div>
</body>
</html>

------=_NextPart_000_00EF_01DD783E.F5BECA90--
